Järveläinen H A, Orpana A, Perola M, Savolainen V T, Karhunen P J, Lindros K O
Alcohol Research Center, National Public Health Institute, Finland.
Hepatology. 2001 May;33(5):1148-53. doi: 10.1053/jhep.2001.24236.
Twin concordance studies indicate that genetic factors influence the individual susceptibility for alcoholic liver disease (ALD). Both clinical and experimental data suggest that Kupffer cell activation by gut-derived endotoxins and other bacterial products is an important pathogenic factor. Activated Kupffer cells release proinflammatory cytokines, a process that is regulated by the CD14 endotoxin receptor (CD14). Recently, a C-->T (-159) polymorphism in the promoter region of the CD14 gene was detected and found to confer increased CD14 expression. In the present study, the association of CD14 promoter polymorphism with different forms of ALD was examined in 3 separate autopsy series. Among 442 men with valid alcohol-consumption data, 381 men had been moderate or heavy alcohol consumers. The allele frequency of the CD14 promoter genotype, determined by a modified cycle minisequencing technique, was 0.34 (CC), 0.51 (CT), and 0.16 (TT). The T allele was found to be associated with advanced ALD, i.e., with alcoholic hepatitis (odds ratio [OR]: 2.48; P = .018), and especially with cirrhosis (OR: 3.45; P = .004), but not with fatty liver, periportal fibrosis, or bridging fibrosis. The overall age-adjusted risk for cirrhosis was 3.08 (P = .01) for the carriers of the CT genotype, and 4.17 (P = .005) for the homozygous TT genotype. These results suggest that in the relatively isolated Finnish population, the T allele confers increased risk of alcoholic liver damage. In particular, TT homozygotes are at a high risk to develop cirrhosis.
双胞胎一致性研究表明,遗传因素会影响个体对酒精性肝病(ALD)的易感性。临床和实验数据均表明,肠道来源的内毒素和其他细菌产物激活库普弗细胞是一个重要的致病因素。被激活的库普弗细胞会释放促炎细胞因子,这一过程受CD14内毒素受体(CD14)调控。最近,在CD14基因启动子区域检测到一个C→T(-159)多态性,发现它会使CD14表达增加。在本研究中,在3个独立的尸检系列中检测了CD14启动子多态性与不同形式ALD的关联。在442名有有效饮酒数据的男性中,381名男性为中度或重度饮酒者。通过改良的循环微测序技术确定的CD14启动子基因型的等位基因频率为0.34(CC)、0.51(CT)和0.16(TT)。发现T等位基因与晚期ALD相关,即与酒精性肝炎相关(优势比[OR]:2.48;P = 0.018),尤其与肝硬化相关(OR:3.45;P = 0.004),但与脂肪肝、门周纤维化或桥接纤维化无关。CT基因型携带者肝硬化的总体年龄调整风险为3.08(P = 0.01),纯合子TT基因型为4.17(P = 0.005)。这些结果表明,在相对孤立的芬兰人群中,T等位基因会增加酒精性肝损伤的风险。特别是,TT纯合子患肝硬化的风险很高。